This bill adds a new section to chapter 18.64 RCW requiring pharmacies that dispense continuous glucose monitoring (CGM) equipment to maintain a sufficient supply of monitoring sensors so they can provide prompt replacement when a patient has an equipment malfunction or is facing an emergency. It creates a new procedural obligation on pharmacies rather than amending an existing crime or penalty. Under the bill, a pharmacy with a physical location must have enough sensors on hand to provide a same-day replacement to a patient in those circumstances. A mail-order pharmacy must mail a replacement sensor no later than the next business day, or if that is not possible, mail it as soon as practicable; the bill defines “promptly” for mail-order purposes using that standard. The text does not quantify what constitutes a “sufficient supply,” does not define “continuous glucose monitoring equipment” or “monitoring sensors,” and does not specify any enforcement mechanism, penalties, exceptions, patient eligibility, or payment and insurance interactions. It is not clear from the provided excerpt whether related provisions appear elsewhere in the bill.

If enacted, patients with a malfunctioning continuous glucose monitor will be able to get a replacement sensor the same day from a neighborhood pharmacy or receive a mailed replacement from a mail-order pharmacy no later than the next business day (or as soon as practicable if next-day mailing isn't possible), improving speed of access in emergencies. This will require physical pharmacies to hold on-hand replacement sensors and mail-order pharmacies to maintain inventory and faster shipping processes so they can meet the stated timelines. The main impacts fall on pharmacies: they will have new inventory and logistics responsibilities that are likely to increase carrying costs, staffing or courier expense, and operational complexity, with smaller pharmacies probably feeling the strain more. The bill text leaves key practical details unanswered — it does not quantify how many sensors count as a “sufficient supply,” does not specify enforcement or penalties, and does not say who pays for replacement sensors or how insurers are involved — so some implementation and cost-allocation questions remain unclear.